IC
HRTX icon

IEQ Capital’s Heron Therapeutics HRTX Stock Holding History

IEQ Capital’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2K Buy
96,612
+29,646
+44% +$23.8K ﹤0.01% 1994
2026
Q1 		$53.6K Buy
66,966
+49,978
+294% +$57.9K ﹤0.01% 1839
2025
Q4 		$22.1K Sell
16,988
-62,037
-79% -$76.6K ﹤0.01% 1825
2025
Q3 		$99.6K Buy
+79,025
New +$125K ﹤0.01% 1766

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

IEQ Capital's HRTX Position: Q2 2026 in Review

IEQ Capital increased its Heron Therapeutics (HRTX) stake by 44% in Q2 2026, buying an estimated $23.8K and bringing the position to 96,612 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

IEQ Capital first reported a position in HRTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $99.6K in Q3 2025. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • IEQ Capital held 96,612 shares of Heron Therapeutics worth $41.2K as of Q2 2026.
  • IEQ Capital bought 29,646 Heron Therapeutics shares in Q2 2026, an estimated $23.8K.
  • Heron Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1994 holding.
  • IEQ Capital first reported a position in Heron Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • IEQ Capital's Heron Therapeutics position peaked at $99.6K in Q3 2025.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.